GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » PB Ratio

Neurotech International (ASX:NTI) PB Ratio : 15.60 (As of May. 18, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-18), Neurotech International's share price is A$0.078. Neurotech International's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.01. Hence, Neurotech International's PB Ratio of today is 15.60.

Warning Sign:

Neurotech International Ltd stock PB Ratio (=14.8) is close to 10-year high of 15

The historical rank and industry rank for Neurotech International's PB Ratio or its related term are showing as below:

ASX:NTI' s PB Ratio Range Over the Past 10 Years
Min: 0.23   Med: 3.72   Max: 15.6
Current: 15.6

During the past 7 years, Neurotech International's highest PB Ratio was 15.60. The lowest was 0.23. And the median was 3.72.

ASX:NTI's PB Ratio is ranked worse than
96.33% of 791 companies
in the Medical Devices & Instruments industry
Industry Median: 2.27 vs ASX:NTI: 15.60

During the past 12 months, Neurotech International's average Book Value Per Share Growth Rate was -50.00% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Neurotech International was -43.90% per year. The lowest was -43.90% per year. And the median was -43.90% per year.

Back to Basics: PB Ratio


Neurotech International PB Ratio Historical Data

The historical data trend for Neurotech International's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International PB Ratio Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial 10.00 - 8.83 35.00 8.00

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.00 35.00 6.90 8.00 13.80

Competitive Comparison of Neurotech International's PB Ratio

For the Medical Devices subindustry, Neurotech International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurotech International's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neurotech International's PB Ratio distribution charts can be found below:

* The bar in red indicates where Neurotech International's PB Ratio falls into.



Neurotech International PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Neurotech International's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.078/0.005
=15.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Neurotech International  (ASX:NTI) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Neurotech International PB Ratio Related Terms

Thank you for viewing the detailed overview of Neurotech International's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurotech International (ASX:NTI) Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013